Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Pfizer, inc. symbols : Nvs save search
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
Published: 2024-03-07 (Crawled : 12:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.04%
H: 0.44%
C: -1.51%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -2.08%
H: 0.13%
C: -0.57%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.36%
H: 0.34%
C: -0.54%
XFOR | $1.255 4.58% 4.38% 3M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: -4.98%
EYPT | $17.665 0.94% 0.93% 1.5M
|
Health Technology
|
| O: 2.56%
H: 1.37%
C: -4.13%
AQST | $4.11 -8.67% -9.49% 2.3M
|
Health Technology
|
| O: 1.79%
H: 12.3%
C: 10.94%
ALKS | $23.86 0.42% 0.42% 2.4M
|
Health Technology
|
| O: 1.11%
H: 0.96%
C: 0.65%
Orphan Drugs Market Projection: BCC Research Anticipates a Staggering $415.2 Billion Valuation by 2028, Reflecting Soaring Global Demand
Published: 2024-02-09 (Crawled : 10:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K
|
Health Technology
|
| O: -0.91%
H: 3.88%
C: 3.88%
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: -2.6%
H: 2.26%
C: 1.44%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -2.46%
H: 0.0%
C: 0.0%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 4.66%
H: 0.0%
C: -3.92%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.04%
H: 0.11%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.37%
H: 0.21%
C: 0.05%
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.11%
H: 0.0%
C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -1.28%
H: 1.05%
C: -0.72%
research global market
Global Sustained Release Coatings Markets, 2018-2022 and 2023-2028: Growing Demand for Controlled Drug Delivery Boosts Expansion
Published: 2024-02-01 (Crawled : 17:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.29%
H: 0.0%
C: -1.38%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.07%
H: 0.83%
C: 0.7%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.55%
H: 0.79%
C: 0.25%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 1.27%
H: 1.87%
C: 1.73%
EMN | $96.42 0.42% 0.0% 700K
|
Process Industries
|
| O: 0.79%
H: 0.8%
C: 0.77%
drug expansion global growing
Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published: 2024-01-24 (Crawled : 17:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.39%
H: 0.82%
C: -0.74%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.22%
H: 0.43%
C: -0.39%
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: -63.33%
H: 263.64%
C: 127.27%
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.1%
H: 0.43%
C: -0.04%
AUTL | $4.51 -6.04% -6.43% 1.4M
|
Health Technology
|
| O: -0.91%
H: 11.52%
C: 4.94%
drug report t-cell global therapy market
Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions - December 8, 2023
Published: 2023-12-08 (Crawled : 16:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.29%
H: 0.4%
C: 0.4%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.07%
H: 1.1%
C: 0.45%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.19%
H: 0.35%
C: 0.2%
kisqali breast risk novartis
Active Pharmaceutical Ingredients Market to Surpass $372.4 Billion, Globally, by 2030 at 6.8% CAGR: Coherent Market Insights (CMI)
Published: 2023-12-08 (Crawled : 15:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 3.4K
|
n/a
|
| O: -20.0%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.29%
H: 0.4%
C: 0.4%
PPCB | $0.001 -41.86% 11M
|
Manufacturing
|
| O: 0.0%
H: 2.61%
C: -4.35%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.07%
H: 1.1%
C: 0.45%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.19%
H: 0.35%
C: 0.2%
active market
Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions
Published: 2023-12-08 (Crawled : 14:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.29%
H: 0.4%
C: 0.4%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.07%
H: 1.1%
C: 0.45%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.19%
H: 0.35%
C: 0.2%
kisqali breast risk novartis
Global Synthetic Hormones Market Analysis and Forecast, 2023-2033: Focus on Product Type, Application, Route of Administration, End User, Region, and Competitive Landscape
Published: 2023-11-25 (Crawled : 00:20) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
| Email alert
Add to watchlist
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
global market
Global Vaginitis Therapeutics Market Size Projected to Reach USD 7.20 Billion By 2032, With 8.1% CAGR Growth: Polaris Market Research
Published: 2023-11-23 (Crawled : 15:30) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
reach research global therapeutics market
Anti-inflammatory Therapeutics Market Size to Hit US$ 149.5 billion by 2031 | Exclusive Study by Transparency Market Research
Published: 2023-10-30 (Crawled : 09:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -4.67%
H: 4.9%
C: 4.9%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.76%
H: 0.0%
C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.43%
H: 1.46%
C: 1.03%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.69%
H: 0.25%
C: -0.07%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.39%
H: 0.79%
C: 0.64%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 2.29%
H: 0.44%
C: -0.23%
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 2.87%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
research therapeutics study market
Novartis Kisqali® NATALEE analysis reinforces consistent reduction in risk of recurrence across key subgroups of patients with early breast cancer
Published: 2023-10-20 (Crawled : 10:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.42%
H: 0.16%
C: -1.32%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.6%
H: 0.61%
C: -0.56%
kisqali breast cancer risk novartis
Dyadic Appoints Doug Pace to Its Executive Leadership Team
Published: 2023-10-09 (Crawled : 13:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.21%
H: 1.24%
C: 0.42%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.01%
H: 0.47%
C: 0.45%
DYAI A | $1.61 1.26% 1.24% 14K
|
Health Technology
|
| O: -2.45%
H: 0.0%
C: -2.01%
RNA Therapeutics Market worth $18.0 billion | MarketsandMarkets
Published: 2023-09-15 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 3.0%
H: 0.0%
C: -3.43%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.26%
H: 1.04%
C: 0.03%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.51%
H: 0.26%
C: -0.72%
SRPT | $115.53 -0.88% -0.9% 640K
|
Health Technology
|
| O: -0.27%
H: 0.54%
C: -0.84%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 0.16%
H: 2.0%
C: 1.42%
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: -0.57%
H: 0.35%
C: -1.11%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.17%
H: 0.48%
C: -0.82%
ARWR | $22.33 -1.24% -1.25% 960K
|
Health Technology
|
| O: 0.16%
H: 0.46%
C: -5.46%
ALNY | News | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.74%
H: 2.42%
C: -3.47%
therapeutics market
Optic Nerves Disorder Treatment Market Rises: North America Takes the Helm
Published: 2023-09-14 (Crawled : 00:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.84%
H: 0.0%
C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.47%
H: 0.41%
C: -0.26%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.28%
H: 1.0%
C: 0.76%
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 1.78%
H: 1.76%
C: 1.07%
america treatment market
Decoding the Global Vasectomy Market 2023: Trends, Strategies, and Regulatory Insights
Published: 2023-09-04 (Crawled : 16:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
ENDP | $0.2926 -9.6%
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
| Email alert
Add to watchlist
ENDPQ | $0.0006 -50.0% 3.4K
|
n/a
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
global market
North America Kidney Transplant Research Report 2023
Published: 2023-08-08 (Crawled : 22:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.11%
H: 0.53%
C: 0.53%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 3.93%
H: 0.0%
C: -3.08%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.11%
H: 1.29%
C: 0.67%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.07%
H: 0.73%
C: 0.36%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: -1.98%
H: 1.7%
C: 0.81%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.81%
H: 0.0%
C: 0.0%
america report kidney research
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published: 2023-06-30 (Crawled : 23:00) - prnewswire.com
ALKS | $23.86 0.42% 0.42% 2.4M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
NBIX M | $132.03 -0.39% -0.39% 560K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
UCBJY | $63.676 -4.38% 7.2K
|
Manufacturing
| Email alert
Add to watchlist
UCBJF | $126.05 -39.66% 100
|
Health Technology
| Email alert
Add to watchlist
AZNCF | $138.24 -4.19% 800
|
Health Technology
| Email alert
Add to watchlist
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
| Email alert
Add to watchlist
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
| Email alert
Add to watchlist
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
report business life global therapeutics
Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published: 2023-06-27 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.95%
H: 0.19%
C: -0.32%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.19%
H: 0.11%
C: -1.46%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.01%
H: 0.16%
C: -0.32%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.03%
H: 0.12%
C: -0.24%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.91%
H: 0.56%
C: -0.5%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 2.15%
H: 1.18%
C: 0.43%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.06%
H: 0.46%
C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.21%
H: 0.42%
C: 0.13%
report business cancer treat global
Biosimilars Market worth $66.9 billion | MarketsandMarkets
Published: 2023-06-15 (Crawled : 10:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.13%
H: 1.07%
C: 0.86%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.04%
H: 0.78%
C: 0.67%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.06%
H: 1.91%
C: 1.32%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.33%
H: 2.62%
C: 2.43%
market
Novartis Kisqali® significantly reduced the risk of recurrence by 25% across a broad population of patients with early breast cancer; clinically meaningful benefit was consistent across subgroups
Published: 2023-06-02 (Crawled : 12:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.6%
H: 1.07%
C: 0.29%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.03%
H: 0.84%
C: 0.82%
kisqali breast risk novartis
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.